ReviewThe journal of extra-corporeal technology2014
Meaningful outcome measures in cardiac surgery.
Review in The journal of extra-corporeal technology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04303455 (Renin as a Biomarker of Haemodynamic Normalisation), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Renin as a Biomarker of Haemodynamic Normalisation: Associations With Outcomes After Cardiac Surgery
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of N-acetylcysteine in Preventing Acute Kidney Injury and Major Adverse Cardiac Events After Cardiac Surgery: A Meta-Analysis and Trial Sequential Analysis.Frontiers in medicine · 2022Pooled it
- Pre- and Immediate Postoperative Prediction Model for Organ Dysfunction or Death Early After Cardiac Surgery: A Post Hoc Analysis of a Multicenter Randomized Trial.Journal of the American Heart Association · 2026Trial
- Quality of Recovery of Patients Who Underwent Curative Pancreatectomy: Comparison of Total Intravenous Anesthesia Versus Inhalation Anesthesia Using the QOR-40 Questionnaire.World journal of surgery · 2021Trial
- Short-term application of tocilizumab during myocardial infarction (STAT-MI).Rheumatology international · 2018Trial
- Factors that impact the implementation of patient reported outcomes in routine clinical care for peripheral artery disease from the patient perspective.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- What Really Matters to Survivors of Acute Type A Aortic Dissection-A Survey of Patient-Reported Outcomes in the Dutch National Aortic Dissection Advocacy Group.Journal of clinical medicine · 2023Article
- Frailty and perioperative patient-reported disability in patients undergoing cardiac surgery: a pilot study.British journal of anaesthesia · 2022Article
- Review
- STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.The journal of extra-corporeal technology · 2021Article
- Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process.JAMA network open · 2021Article
- Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery.Advances in laboratory medicine · 2020Article
- Minimally invasive aortic valve replacement with central cannulation: A cost-benefit analysis in a developing country.The cardiothoracic surgeon · 2020Article
- Article
- Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery.Scientific reports · 2018Observational
- Disability-free survival after major cardiac surgery: a population-based retrospective cohort study.CMAJ openArticle
- Disability-free survival after coronary artery bypass grafting in women and men with heart failure.Open heartArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most common cardiac surgical procedures are coronary artery bypass graft surgery and aortic or mitral valve repair or replacement. Underlying conditions include coronary artery disease and heart failure, manifesting as exertional angina, dyspnea, and poor exercise tolerance. The major goals of surgery are to alleviate symptoms and improve patient survival. These, therefore, should inform the choice of primary outcome measures in clinical studies enrolling patients undergoing cardiac surgery. Studies focusing on surrogate outcome measures are relied on all too often. Many are of questionable significance and often have no convincing relationship with patient outcome. Traditional "hard endpoint" outcome measures include serious complications and death with the former including myocardial infarction (MI) and stroke. Such serious adverse outcomes are commonly collected in registries, but because they occur infrequently, they need to be large to reliably detect true associations and treatment effects. For this reason, some investigators combine several outcomes into a single composite endpoint. Cardiovascular trials commonly use major adverse cardiac events (MACEs) as a composite primary endpoint. However, there is no standard definition for MACE. Most include MI, stroke, and death; others include rehospitalization for heart failure, revascularization, cardiac arrest, or bleeding complications. An influential trial in noncardiac surgery found that perioperative beta-blockers reduced the risk of MI but increased the risk of stroke and death. Such conflicting findings challenge the veracity of such composite endpoints and raise a far more important question: which of these endpoints, or even others that were unmeasured, are most important to a patient recovering from surgery? Given the primary aims of cardiac surgery are to relieve symptoms and improve good quality survival, it is disability-free survival that is the ultimate outcome measure. The question then becomes: what is disability and how should it be quantified after cardiac surgery?
Indexed as
Identifiers
24779115PMC4557506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.